Ensure Market Access

Broad and quality access depends on engaging all:

The Patient, Payer and Provider

Market success is not dependent upon the multi-year drug development and promised benefits of your drug. Market success is dependent upon Market Access. Navigating today’s shifting healthcare landscape is complicated. Never before has the healthcare industry witnessed such promising treatments entering the marketplace, yet facing so many challenges.

Value is achieved with Comprehensive Services, including:

  • Market Assessment & Insights

    Market Assessment & Insights

    The intelligence you need to validate or inform your strategy across the product life cycle.

    Learn More
  • Global Pricing Data & Software

    Global Pricing Data & Software

    Assess your pricing and launch strategies globally. Answer the complex questions impacting your revenue.

    Learn More
  • Market Access Strategy & Stakeholder Engagement

    Market Access Strategy & Stakeholder Engagement

    Breaking down the complexity of reimbursement and access. Engaging the Patient, Payer and Provider.

    Learn More
  • Global Channel & 3PL

    Global Channel & 3PL

    Distribution from Day 1 including special logistics for regenerative medicine.

    Learn More
  • Specialty & Direct-to-Patient Distribution

    Specialty & Direct-to-Patient Distribution

    Get therapies to patients quickly and effectively. We manage inventory, payer relationships, cash flow and wraparound patient service needs.

    Learn More
  • Affordability Programs

    Affordability Programs

    Help your patients secure treatments by offering options to manage cost.

    Learn More

Ask the Experts: How Does Real World Evidence Ensure Market Access?

With advancements in big data technologies and the sophistication of health information exchange, payers and providers are building analytic capabilities to identify real world unmet needs, along with areas of cost containment and efficiency. The development of digital medicines, apps, wearables, and biosensors that gather and store large amounts of health-related data has also accelerated. So, given the number of converging factors, how do we ensure that patients have access to the medicines they need, when, and where they need them?



Contact Form

  • This field is for validation purposes and should be left unchanged.